Sox9 is an oncogenic transcription factor that induces transformation of mammary stem cells from differentiated breast epithelial cells, which is important for breast cancer development and malignancy [28], and EV miR-140 reduces the expression of this SOX2/SOX9 and works toward reducing stem cell populations [29]. This evidence concerns the gene SOX9 and breast carcinoma.